Background: Hepatocellular Carcinoma (HCC) is the fifth most common malignancy in the world complicating liver cirrhosis in most cases.
As a result, the major hepatological/gastroenterological professional societies worldwide, including the American Association for Study of Liver Disease (AASLD), recommend screening for HCC in high risk patients [10] . Alpha-fetoprotein (AFP) levels and imaging techniques such as ultrasonography are the most common screening modalities used by physicians to detect early HCC [11] . The majority of HCCs are diagnosed in advanced stages, which carries a poor prognosis [12] . Recent curative therapeutic regimens and liver transplantation for early stage HCC encourage physicians to screen high-risk patients [13] .
The aim of our study was to assess the practice of Egyptian physicians in screening patients for HCC.
Material and Methods
The study included 154 physicians from different hospitals all over Egypt who care for patients at risk for HCC development during the period from January 2013 -July 2013. The study included physicians with the following 4 specialties: General practitioners/family medicine, tropical medicine, internal medicine and gastroenterology. The types of health care settings in which the physicians were employed were: Primary health care, Ministry of Health (MOH) general hospitals, University hospitals and private hospitals/clinics.
Questionnaire: We designed a 3-page questionnaire with 20 questions for Egyptian physicians to assess their practice in screening patients for HCCs. Each questionnaire consisted of two parts: (1) Personal information regarding the physician (name, age, specialty and type of health care facility); (2) Professional experience with patients at risk for HCC development with respect to screening, knowledge about the cause and epidemiology of liver diseases, incl. HCC risk.
Questionnaire distribution: The questionnaires were distributed to Egyptian physicians by personal contact, professional conferences and during seminars. The questionnaires were collected immediately after completion. Doctors were also contacted by e-mail with the questionnaire attached and asked to return the completed questionnaire by e-mail. It was also sent through the Gastrointestinal Club, a group in the facebook facilitating scientific contacts.
Ethics and consent:
The survey was approved by the Faculty's Ethics Committee. Further, permission was obtained from all department heads who had been assured that confidentiality would be maintained and ethical principles would be followed. Before distribution of the questionnaires, the aim of the survey was explained to the potential participants who were encouraged to participate without undue pressure.
Statistical analyses:
The data from questionnaires were entered into spread sheets of Microsoft Excel before being transferred to the Statistical Package for Social Sciences (SPSS) software (SPSS Inc., Chicago, IL, USA) version 16 for Windows 7 (Microsoft Corp., Redmond, WA) to be analyzed.
Results
The study included 154 physicians of different age groups, specializations and clinical settings. The aim of the study was to assess the physicians' attitude towards HCC screening, their knowledge regarding different aspects of HCC screening, including screening modalities, as well as awareness of published guidelines. 
1-Knowledge of HCC epidemiology:
Relation with physicians' age: Table ( 2) shows that 76% of doctors older than 45 years and 48% of doctors younger than 45 years think that the HCV genotype is a risk factor for progression of chronic hepatitis C to HCC ( p<0.05).
In both age groups there were otherwise no significant differences regarding the physicians' knowledge about HCC epidemiology, people who should undergo HCC surveillance or the number of deaths that can be prevented by adequate HCC screening. Relation with physicians' specialty: There is significant difference between specialties with respect to patients who should be screened for HCCs (Table 3) : 90% of physicians in tropical medicine, internal medicine and gastroenterology consider patients with chronic HBV or HCV infection and/or liver cirrhosis at risk to develop an HCC as compared to 67% of physicians in other specialties, such as general physicians/family doctors, radiologists or general surgeons ( p<0.05). By comparison, 11 % of physicians in tropical medicine, internal medicine and gastroenterology think that everyone should be screened for HCC as compared to 29% of general practitioners. With respect togender, 36% of physicians in tropical medicine, internal medicine and gastroenterology consider gender as a risk factor for HCC development compared to 12% of general practitioners ( p<0.05).
There were no significant differences with respect to other aspects, such as the number of deaths that can be prevented by HCC screening or the fact that HCCs are the leading cause of tumor deaths in Egypt. Relation with physicians' medical qualification: Table (4) shows a significant difference in awareness regarding HCC risk factors depending on the qualification of the doctors: 52% of doctors with a MD degree, 17% of doctors with a master degree or diploma and 32% of doctors with a MBBCh think that patients with a family history of HCC should be screened for HCC ( p<0.05). There is also a significant difference in knowledge about the risk factors for disease progression depending on the qualification of the doctors: 68% of doctors with a MD degree, 48% of doctors with a master degree or diploma and 40% of doctors with a MBBCh think that the HCV genotype is a risk factor for progression of the disease; with respect to gender 48% of doctors with a MD degree, 22% of doctors with a master degree or diploma and 16% of doctors with a MBBCh are aware that gender is the risk factor for disease progression (p<0.05).
There is no significant difference in awareness regarding other aspects, such as the number of deaths from HCC that can be prevented by appropriate screening or the most common cause of death of HCC patients in Egypt. There is no significant difference in knowledge with respect to other aspects, such as of the number of deaths that can be prevented by appropriate screening and the most common cause of death in HCC patients. 
2-Knowledge about screening modalities, educational resources and guidelines:
Relation with doctors' age: Table ( 6) shows a significant difference in knowledge about the most important investigations for HCC screening, depending on the physicians' age: 58% of doctors <45 years and 76% of doctors >45 years of age think that ultrasound (US) is the most important investigation; 16% of doctors <45 years and no doctor >45 years think that computer tomography (CT) is the method of choice in HCC screening. 75% of doctors <45 years and 93% of doctors >45 years think that treating HBV can reduce HCC incidence, while 25% of doctors <45 years and 7% of doctors >45 years do not think that treating of HBV can reduce HCC incidence ( p<0.05).
There is no significant difference in other aspects of HCC screening such as screening intervals in high risk groups, knowledge about the existence of guidelines for the management of HCC, the prediction of increased HCC risk by elevated HCV RNA and ALT levels and the opinion regarding the second and third most important examinations in HCC screening. Relation with physicians'medical specialty: Table (7) shows a significant difference in opinion between different medical specialties with respect to the optimal screening interval in high risk groups (p<0.05): 65% of physicians in tropical medicine, internal medicine and gastroenterology think that the optimal screening interval is 3 months while only 38% of physicians in other specialties think so; 35% of physicians in tropical medicine, internal medicine and gastroenterology think that the screening interval in high risk groups should be 6 months or more; 62% of physicians in other specialties share this opinion.
There were no significant differences with respect to other aspects, such as the most important examination in HCC screening, the second and third most important examination in HCC screening, the reduction of the HCC incidence by treatment of HBV infection, the existence of guidelines for the management of HCC and the predictive value of elevated HCV RNA and ALT levels for HCC development. Relation with physicians' highest qualification: Table (8) shows a significant difference of opinion between doctors with different qualifications with respect to the most important investigation in HCC screening (p<0.05): 73% of doctors with an MD degree, 55% of doctors with a master degree and diploma and 56% of doctors with an MBBCH think that US is the most important screening tool to detect HCCs. There is also a significant difference in opinion with respect to the third most important investigation in screening for HCCs ( p<0.05) as well as with respect to the optimal screening interval (p<0.05): 60% of doctors with a MB BCh, 50% of doctors with a master degree and diploma and 71 % of doctors with a MD degree think that the screening interval for high risk group should be 3 months, while 40% of doctors with a MBBCh, 50% of doctors with a master degree or diploma and 29% with a MD degree think that the screening <45 interval for high risk groups should be 6 months. 52% of doctors with a MB BCh, 33% of doctors with a master degree or diploma and 83% of doctors with a MD degree know guidelines for the management of HCC patients, while 48% of doctors with a MBBCh, 67% of doctors with a master degree and diploma and 17% of doctors with a MD used no guidelines for the management of HCCs (p<0.05).
There were no significant differences with respect to other aspects, such as the reduction of HCC incidence by treatment of HBV infection and the predictive value of elevated HCV RNA and ALT levels for HCC development. There is no significant difference with respect to other aspects, such as the 3 rd most important examination in HCC screening, the screening interval for high risk group and the predictive value of elevated HCV RNA and ALT for the individual HCC risk.
3-Physicians' practice and attitude towards HCC:
Relation with physicians' age: Table ( 10) shows a significant difference of opinion regarding HCC surveillance with respect to the physicians' age (p<0.05): 18% of doctors <45 years and 35% of doctors >45 years screen of liver cancer while 82% of doctors <45 years and 65% of doctors >45 years do not.
There is no significant difference in opinion regarding other aspects, such as the clinical care of patients with HCV cirrhosis who responded to antiviral therapy or hemochromatosis as well as with respect to number of HCCs discovered accidentally per month and the number of HCC patients that physicians care for. Relation with physicians' medical specialty: Table ( 11) shows a significant difference in the care for patients with hemochromatosis depending on the physicians' medical specialty (p<0.05): 72% of physicians in tropical medicine, internal medicine and gastroenterology and 50% in other specialties screen patients of hemochromatosis for HCCs while 28% of physicians in tropical medicine, internal medicine and gastroenterology and 50% of general practitioners do not.
There is no significant difference with respect to other aspects, such as HCC screening of patients with HCV cirrhosis with Sustained Virological Response (SVR), the number of HCC cases discovered accidentally per month and the number of HCC patients the physicians care for. Relation with hospital setting: Table (13) shows a significant difference in the number of accidentally discovered HCCs per month between the physicians' hospital setting (p<0.05): 10% of doctors working in University hospitals and 54% of MOH doctors do not discover any HCC per month while 90% of doctors working in University hospitals and 46% of MOH doctors discover one or more cases per month. There is also a significant difference with respect to the number of HCC patients that doctors care for depending on the physicians' hospital setting (p<0.05): 9% of doctors working in University hospitals and 54% of MOH doctors do not care for any HCC patient while 91% of doctors working in University hospitals and 46% of MOH doctors see one or more HCC patient in their practice. 
Discussion

Knowledge of HCC epidemiology:
The results from the questionnaire show that the majority of doctors think that individuals at risk requiring screening for HCC are patients with chronic hepatitis B or C and patients with liver cirrhosis, consistent with the Practice Guidelines from the American Association of the Study of Liver Diseases (AASLD) from 2005 and from the European Association for the Study of the Liver (EASL) from 2001 which recommended HCC surveillance for patients at high risk of developing HCC [8] . Patients at high risk are those with liver cirrhosis and those with chronic HBV infection irrespective of cirrhosis [14, 15] .
Cairo Liver Center evaluated in a retrospective study between 2003 and 2008 the effect of surveillance on the early detection of HCC in patients with liver cirrhosis. This cohort was compared to non-screened cirrhosis patients who presented with first symptoms or incidentally. The study clearly showed that surveillance doubled the chance of HCC detection at an early Barcelona Liver Cancer Center (BCLC) stage with a chance for successful loco-regional ablation or liver transplantation. Therefore, the implementation of HCC surveillance in Egypt is recommended [16] .
Chronic hepatitis B infection accounts for about 50% of all HCC cases worldwide. At the same time, in approx. 40% of patients with chronic HBV infection HCCs develops in a non-cirrhotic liver.
Therefore, HCC screening is recommended in all patients of chronic HBV infection [17] . In Egypt, the increasing HCC incidence is due to the high prevalence of HCV infection [10] , estimated to be around 14% in the general population [8] .
The questionnaire results showed that most of doctors agree that more than 30% of deaths can be prevented by HCC screening, consistent with results from a multiple-choice survey study in the USA [18] , based on the AASLD Practice Guidelines. The questionnaire asked for an estimate of the proportion of deaths from HCC that can currently be prevented by suitable screening. Most gastroenterologists stated that appropriate screening and surveillance could prevent 20-50% of deaths [18] .
In the USA, there was no significant difference of opinion based on the physicians' age, specialty, highest qualification or hospital setting.
The questionnaire results indicated that most doctors' know that co-infection, gender, HCV genotype and obesity are risk factors for progression of the liver disease to HCC. This is in line with the data of Crockett et al., [19] demonstrating that HBV-HCV co-infection is a predictive factor for HCC development. The contribution of the gender to the progression to HCC has also been shown by Buch et al., [20] , demonstrating that the natural history of HCC is different between men and women.
Our results showed that the majority of doctors consider chronic HCV infection as the leading cause of HCC in Egypt, reflecting the high prevalence of HCV infection in the general population of around 14% [8] that is responsible for to the increasing incidence of HCCs in Egypt [10] .
Our results further showed that doctors consider cancer as the main cause of death in HCC patients, followed by decompensated liver cirrhosis and its complications such as bleeding from varices in other HCC patients. This is consistent with the findings of Couto et al., [21] , demonstrating that 57% of patients with unresectable HCC died from cancer progression while 43% died from complications of liver cirrhosis, including sepsis, GI bleeding and renal failure.
Knowledge of screening modalities, educational resources and guidelines:
Our questionnaire revealed that 74% of University doctors and 46% of MOH doctors consider US as the most important HCC screening test, consistent with many studies in the USA. This is based on its adequate sensitivity, specificity, its low cost, non-invasive character and wide availability. The effectiveness of US screening for HCCs in the USA depended on the screening frequency, the experience of the examiner and the nature of the patients' liver disease. The sensitivity of US for HCC detection was variable and ranged between 35% and 84%, depending on the expertise of the operator as well as on the US equipment [22] .
AFP alone as screening test is no longer considered adequate for HCC screening and surveillance by AASLD and EASL guidelines due to the high rate of false-positive and false-negative results in patients with chronic liver disease. Nevertheless, AFP alone may be used if US is not available [8] .
Asked about the second and third choice of screening tests, some doctors favor AFP while others favor CT as the second choice for HCC screening. While CT is an attractive imaging modality for HCC screening because it can detect lesions in cirrhotic livers, allows lesion characterization and contributes to clinical staging, it is expensive and its use as screening test is difficult, especially in countries with limited resources and high HCC prevalence, such as Egypt.
Cost-effectiveness studies of HCC screening revealed that screening European patients with Child-Pugh class A cirrhosis using serum AFP and US every 6 months costs about 74,000 U$ for each HCC detected, while CT alone every 6 months costs about 101.000U$ [23] .
With respect to the screening interval in high risk patients our study showed that most doctors consider 3 months as optimal while some consider 6 or more months as adequate. The 6-months screening interval for high risk groups has been adopted by many organizations, such as the AASLD, the EASL, the APASL (Asian Pacific Association for the Study of the Liver) and the NCCN (National Comprehensive Cancer Network). The recommendation of the screening interval of 3 months is based on the estimate that the tumors >1 cm in diameter may double every 2 months [24] .
With respect to the physicians' age, our study revealed that 93% of doctors older than 45 years and 75% of doctor younger than 45 years think that treatment of HBV infection can reduce the HCC incidence in Egypt, similar to the study of Lok et al., [25] .
It is known that HBV infection is oncogenic, resulting in HCC development also in non-cirrhotic livers. The relative HCC risk of HBV carriers is estimated to be 100-200-fold higher than that of non-carriers [5] .
Our questionnaire results show in addition that 93% of doctors older than 45 years and 75% of doctors younger than 45 years use guidelines in the management of HCC patients while 17% of doctors older 45 and 25% of doctors younger than 45 years do not. The significant difference in the use of guidelines by physicians of different age may be due to the following reasons: Most of the older doctors hold a higher medical degree than younger physicians. Further, older doctors had more opportunities to attend medical conferences to update their knowledge. Further, some of them are professors teaching their students the most advanced medical knowledge. The questionnaire results further show that about 71 % of doctors in MOH do not know about guidelines for the management of HCC. This may be due to the limited interest of managers and division heads in these hospitals to adapt existing protocols or guidelines appropriate for Egypt as well as the Egyptian government considering other endemic diseases of higher priority with respect to guidelines and screening programs.
Physicians' practice and knowledge about HCC:
The questionnaire results clearly show that the majority of doctors do not implement or recommend HCC surveillance according to international guidelines. This may be due to limited information about the benefits and importance of screening programs that allow detecting HCCs at an early, potentially curable stage, resulting in improved patient survival. It also may be due to the unawareness of the Egyptian Ministry of Health and government about the importance of HCC screening among high risk groups which overall my save money, last but not least money that must be spent for the palliative care for HCC patients.
Screening for HCC in Egypt depends on the specialty and qualification of physicians' with general practitioners and family doctors having the lowest rate of practical implementation of HCC screening compared to other doctors. This may be due to the lack of facilities for HCC screening in primary care settings and the limited knowledge of these doctors about the importance of HCC screening among high risk group and about epidemiology of HCCs, being the second most frequent cause of cancer death in Egypt after bladder cancer.
The questionnaire results demonstrated that most doctors screened patients with liver cirrhosis due to chronic HCV infection who responded to antiviral treatment, consistent with a study showing that these patients should still undergo surveillance [26] . A more recent study by Singal et al., [27] showed that patients with cirrhosis and a SVR had a relative risk for HCC of 0.35 compared to nonresponders, resulting in HCC development in 5% of patients with a SVR, warranting regular posttreatment surveillance.
Finally, the answers to the questionnaire showed that about 70% of doctors identified one or more HCCs per month. Further, 94% of doctors feel that the HCC incidence in Egypt is increasing while 3% are not sure. In fact, in Egypt the HCC incidence (10-120 cases per 100.000 population and year), has nearly doubled from 4.0% in 1993 to 7.2% in 2002 among patients with chronic liver disease [16] .
Conclusions:
In Egypt, physicians specialized in Tropical Medicine, Internal Medicine or Gastroenterology, older than 45 years, having an MD degree and working in University hospitals are better informed about the HCC epidemiology, the appropriate screening modalities, educational resources and practice guidelines than physicians with other specialties.
